Barcode Five Rights System



Use Barcode to prevent medication errors



ADERS ® is a barcode point of care, (BPOC), solution

Request Info





 






Practical Compliance Solutions, Corp. helps care facilities reduce risk at the patient's bedside. Our five rights barcode solution is the easiest to implement. Our barcode point of care system can help prevent medication errors in hospitals, long term care facilities, and assisted living communities.

ADERS ® is our barcode solution for the healthcare industry. It helps eliminate medication errors by allowing caregivers to scan NDC barcodes at the patient's bedside, verifying right patient, right drug, right time, right dose, and right route of administration. For more information click the products menu or send us a web request from our Contact menu. Ask for a DEMO CD. It is the full product that is licensed for an evaluation period.

We are offering a 30 day no-obligation free trial of the ADERS ® software. Care facilities can easily determine if ADERS ® is right for them by using the software as a pilot for a single unit or ward. Click here to download a Microsoft Project plan showing how you can implement a five rights point of care barcode pilot in less than a week. If you Don't own MS Project 2003, then here is a PDF copy just to see.... Download Adobe PDF Data Sheet

View a PowerPoint Presentation of ADERS ®.





Current Patient Safety and Drug Safety Updates from the FDA


FDA Press Releases RSS Feed

Coronavirus (COVID-19) Update: FDA Takes Steps to Streamline Development of Tests With At-Home Sample Collection
Fri, 29 May 2020 11:55:03 EDT

  FDA taking steps to further support the development of COVID-19 tests for at-home self-collection by including a voluntary EUA template for at-home sample collection kits to its website.

FDA Approves New Option to Treat Heavy Menstrual Bleeding Associated with Fibroids in Women
Fri, 29 May 2020 11:48:53 EDT

  FDA Approves New Option to Treat Heavy Menstrual Bleeding Associated with Fibroids in Women

FDA Alerts Patients and Health Care Professionals to Nitrosamine Impurity Findings in Certain Metformin Extended-Release Products
Thu, 28 May 2020 19:32:13 EDT

  FDA Alerts Patients and Health Care Professionals to Nitrosamine Impurity Findings in Certain Metformin Extended-Release Products

Coronavirus (COVID-19) Update: Daily Roundup May 28, 2020
Thu, 28 May 2020 19:06:54 EDT

  Coronavirus (COVID-19) Update: Daily Roundup

FDA Approves First Drug to Image Tau Pathology in Patients Being Evaluated for Alzheimer’s Disease
Thu, 28 May 2020 16:22:32 EDT

  FDA approved Tauvid for IV injection, the first drug used to help image a distinctive characteristic of Alzheimer’s disease in the brain called tau pathology. Tauvid is a radioactive diagnostic agent for adult patients with cognitive impairment who are being evaluated for Alzheimer’s disease.

Coronavirus (COVID-19) Update: Daily Roundup May 27, 2020
Wed, 27 May 2020 20:34:40 EDT

  Coronavirus (COVID-19) Update: Daily Roundup

Coronavirus (COVID-19) Update: FDA Provides New Tool to Aid Development and Evaluation of Diagnostic Tests That Detect SARS-CoV-2 Infection
Wed, 27 May 2020 18:48:22 EDT

  FDA new step to support the evaluation of diagnostic tests for COVID-19, by providing a SARS-CoV-2 reference panel. Reference panels are needed to ensure the quality of the tests, validation of new assays, test calibration, and monitoring of assay performance.

FDA Approves Only Drug in U.S. to Treat Severe Malaria
Tue, 26 May 2020 20:10:22 EDT

  FDA has approved artesunate for injection to treat severe malaria in adult and pediatric patients.

FDA Approves First Treatment for a Form of Bladder Dysfunction in Pediatric Patients as Young as 2 Years of Age
Tue, 26 May 2020 18:08:03 EDT

  FDA Approves First Treatment for a Form of Bladder Dysfunction in Pediatric Patients as Young as 2 Years of Age

Coronavirus (COVID-19) Update: Daily Roundup May 26, 2020
Tue, 26 May 2020 17:54:13 EDT

  Coronavirus (COVID-19) Update: Daily Roundup

Coronavirus (COVID-19) Update: Daily Roundup May 22, 2020
Fri, 22 May 2020 15:38:25 EDT

  Coronavirus (COVID-19) Update: Daily Roundup

Coronavirus (COVID-19) Update: Daily Roundup May 21, 2020
Thu, 21 May 2020 18:16:42 EDT

  Coronavirus (COVID-19) Update: Daily Roundup

Coronavirus (COVID-19) Update: FDA Provides Promised Transparency for Antibody Tests
Thu, 21 May 2020 14:45:55 EDT

  The FDA has posted a list of antibody tests that are no longer being offered under the March 16, 2020 Policy, which is sometimes called the “notification list.”

FDA Releases Report on Investigation into Fall 2019 Outbreaks of Illnesses Tied to Romaine Lettuce
Thu, 21 May 2020 13:44:31 EDT

  FDA released the findings of an investigation into the Fall 2019 Outbreaks of Illnesses Tied to Romaine Lettuce

Coronavirus (COVID-19) Update: Daily Roundup May 20, 2020
Wed, 20 May 2020 17:07:21 EDT

  Coronavirus (COVID-19) Update: Daily Roundup

USDA, FDA Strengthen U.S. Food Supply Chain Protections
Tue, 19 May 2020 18:14:02 EDT

  The following statement is attributed to Mindy Brashears, Ph.D., USDA Under Secretary for Food Safety, and Frank Yiannas, FDA Deputy Commissioner for Food Policy and Response

Coronavirus (COVID-19) Update: Daily Roundup May 19, 2020
Tue, 19 May 2020 16:49:59 EDT

  Coronavirus (COVID-19) Update: Daily Roundup

Coronavirus (COVID-19) Update: FDA Collaborations Promote Rigorous Analyses of Real-World Data to Inform Pandemic Response
Tue, 19 May 2020 10:38:45 EDT

  FDA is applying data from diverse sources to inform its response to COVID-19. FDA has entered into an agreement with Aetion to collaborate on advanced analytical techniques to answer urgent COVID-19 research questions.

Coronavirus (COVID-19) Update: Daily Roundup May 18, 2020
Mon, 18 May 2020 18:28:32 EDT

  Coronavirus (COVID-19) Update: Daily Roundup

Coronavirus (COVID-19) Update: FDA Authorizes First Standalone At-Home Sample Collection Kit That Can Be Used With Certain Authorized Tests
Sat, 16 May 2020 09:43:52 EDT

  FDA informs public about an emergency use authorization for an at-home collection kit for use with multiple authorized COVID-19 diagnostic tests

Food and Drugs Administration--Recalls/Safety Alerts

Apotex Corp. Issues Voluntary Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets 500mg Due to the Detection of N-nitrosodimethylamine (NDMA)
Wed, 27 May 2020 00:00:00 EDT

  Apotex Corp is voluntarily recalling all lots of Metformin Hydrochloride Extended-Release Tablets, USP 500mg within expiry to retail level. Apotex was notified by the U.S. Food and Drug Administration (US FDA) that one lot of Metformin Hydrochloride Extended-Release Tablets, USP was tested and showe

Acella Pharmaceuticals, LLC Issues Voluntary Nationwide Recall of Certain Lots of NP Thyroid® (Thyroid Tablets, USP) Due to Super Potency
Fri, 22 May 2020 15:00:00 EDT

  Acella Pharmaceuticals, LLC is voluntarily recalling a total of 13 lots of 30-mg, 60-mg and 90-mg NP Thyroid® (thyroid tablets, USP) to the consumer level. The products are being recalled because our testing has found these lots to be superpotent. The product may have up to 115.0% of the labeled amo

Johnson Sea Products Issues Allergy Alert on Undeclared Wheat & Soy in “Home Style Crab Cakes”
Fri, 22 May 2020 00:00:00 EDT

  Johnson Sea Products of Coden, AL, is recalling its 12oz package of frozen “Home Style Crab cakes” because they contain undeclared ingredients of wheat and soy. People who have allergies to wheat or soy run the risk of serious or life-threatening allergic reaction if they consume these products.

New Hoque and Sons, Inc. Recalls Radhuni Curry Powder Because of Possible Health Risk
Thu, 21 May 2020 14:14:00 EDT

  New Hoque and Sons, Inc. of Maspeth, NY is recalling Radhuni Curry Powder, contained in 400g plastic bottles, because it has the potential to be contaminated with Salmonella , an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others wi

Biota Biosciences Issues Voluntary Nationwide Recall of Cannabidiol (CBD) Complex, Curcumin Complex, and Cannabidiol + Curcumin Injectables Because They Were Marketed Without FDA Approval
Wed, 20 May 2020 00:00:00 EDT

  Biota Biosciences is voluntarily recalling the following lots in the table below of Cannabidiol (CBD) Complex, Curcumin Complex, and Cannabidiol + Curcumin Injectables to the customer level.

Kent Nutrition Group Recalls Home Fresh Starter Amp Crumble Because of Elevated Salt Levels
Wed, 20 May 2020 00:00:00 EDT

  Kent Nutrition Group (KNG) of Muscatine, Iowa is voluntarily recalling 27- 25 lb.bags of Home Fresh Starter AMP Crumble from a single batch due to elevated salt levels, which can present illness or death to poultry.

Ramar Foods Recalls Mint Chocolate Chip With Hidden Spinach Ice Cream Because of Possible Health Risk
Thu, 14 May 2020 21:51:00 EDT

  Ramar Foods of Pittsburg, CA, is recalling its 14 ounce packages of Peekaboo branded Mint Chocolate Chip with Hidden Spinach Ice Cream product out of an abundance of caution because of the potential contamination of Listeria monocytogenes, an organism which can cause serious and sometimes fatal infe

Mellace Family Brands California Inc. (Johnvince Foods) Recalls Wegmans Semi-Sweet Chocolate nonpareils, 18.5oz (1lb 2.5oz) 524g Due to Undeclared Milk Allergen
Thu, 14 May 2020 00:00:00 EDT

  MELLACE FAMILY BRANDS CALIFORNIA INC. (JOHNVINCE FOODS),located at 655 North River Road, Unit C, Warren Ohio 44483-2254, is recalling Wegmans Semi-Sweet Chocolate nonpareils, 18.5oz (1lb 2.5oz) 524g because it has undeclared MILK allergen on the retail label. People who have an allergy or severe sen

Summitt Labs Issues Voluntary Nationwide Recall of KORE ORGANIC Watermelon CBD Oil Due to High Lead Results
Tue, 12 May 2020 09:36:00 EDT

  Summitt Labs is voluntarily recalling Batch#730 Lot#K018 of KORE ORGANIC Watermelon CBD Oil Tincture, 30 ml bottle, 15mg 450x to the consumer level. The Florida Department of Agriculture and Consumer Services tested a random sample and found the product to contain lead levels at 4.7 ppm.

UNFI Voluntarily Recalls Wild Harvest® Organic Basil Due to Possible Health Risk
Mon, 11 May 2020 00:00:00 EDT

  United Natural Foods, Inc. (UNFI) is initiating a voluntary recall of a limited quantity of Wild Harvest® Organic Basil distributed out of UNFI’s Hopkins, MN distribution center to select retailers in Minnesota between 4/18/2020-5/8/2020. UNFI’s recall is issued out of an abundance of caution becaus

ICU Medical Issues a Voluntary Nationwide Recall of Lactated Ringer's Injection, USP Due to the Presence of Particulate Matter
Fri, 08 May 2020 13:25:00 EDT

  ICU Medical, Inc. is voluntarily recalling one single lot of Lactated Ringer's Injection, USP. The products are being recalled to the hospital/user level due to the presence of particulate matter identified as iron oxide. ICU Medical became aware of this issue through a single customer complaint

Zilk’s Plus Resources Issues Allergy Alert on Undeclared Milk, Soy, and Wheat in Select 12 Oz Bottled Sauces
Fri, 08 May 2020 00:00:00 EDT

  Zilk’s Plus Resources, LLC of Austin, TX announces a voluntary recall for select 12 oz bottles of Pluckers World Famous Wing Sauces because they may contain undeclared allergens.

Becca Cosmetics voluntarily recalls Light Shifter Brightening Concealer
Thu, 07 May 2020 00:00:00 EDT

  Out of abundance of caution, and in line with its commitment to consumer satisfaction and safety, Becca Cosmetics is voluntarily recalling all shades of its Light Shifter Brightening Concealer because a brownish-black material identified as a common household mold was found on the sponge-tip applica

MasterPharm, LLC. Issues Voluntary Nationwide Recall of Finasteride Plus 1.25mg Due to the Presence of an Undeclared Antihypertensive Drug
Wed, 06 May 2020 16:42:00 EDT

  MasterPharm, LLC. is voluntarily recalling 1 lot of Finasteride Plus 1.25mg, capsules to the consumer level. The Finasteride Plus capsules have been found to contain undeclared minoxidil, an antihypertensive drug, at levels greater than those found in FDA approved products. The undeclared minoxidil

The Essential Baking Company Issues Allergen Alert on Undeclared Egg in 84 Loaves of 32 Oz. Sliced Columbia Bread
Tue, 05 May 2020 00:00:00 EDT

  The Essential Baking Company of Seattle, Washington is recalling 84 loaves of 32 oz. Sliced Columbia Bread, expiration date May 6.20, due to undeclared egg. People who have an allergy or severe sensitivity to egg run the risk of serious or life-threatening allergic reaction if they consume this pro

Medifast Inc. Issues Allergy Alert on Undeclared Milk in OPTAVIA Essential Old Fashioned Maple & Brown Sugar Oatmeal
Mon, 04 May 2020 11:04:00 EDT

  Medifast, Inc. of Baltimore, Md., is recalling 24,923 boxes of OPTAVIA Essential Old Fashioned Maple & Brown Sugar Oatmeal because the product may contain undeclared traces of milk.

Mondelēz Global LLC Conducts Voluntary Recall of Limited Quantity of RITZ Cheese Cracker Sandwiches Family Size Product in the U.S. Due to Undeclared Peanut on Outer Packaging
Fri, 01 May 2020 00:00:00 EDT

  Mondelēz Global LLC announced today a voluntary recall of a limited quantity of RITZ Cheese Cracker Sandwiches Family Size (21.6 oz. carton) product in the United States. This recall is being conducted because the outer packaging indicates that the product is Cheese variety, while the individually-

Condies Foods Issues Allergy Alert on Undeclared Soy Allergen in Chicken Salad on Croissant Single Item# 43237 and Chicken Sandwich on White Single Item# 43559
Wed, 29 Apr 2020 16:05:00 EDT

  Condies Foods of Kearns, UT is recalling 165 units of roll chicken salad on croissant single item# 43237 “USE THRU” 03/6/2020 05/6/2020, and sndw chicken sandwich on white single item# 43559 “USE THRU” 03/6/2020 05/2/2020. There is a possibility that this may contain undeclared soy allergen

GSK Consumer Healthcare Recalls Benefiber Healthy Shape Prebiotic Fiber Supplement and Benefiber Prebiotic Fiber Supplement Due to Possible Plastic Contamination from the Bottle Cap
Tue, 28 Apr 2020 00:00:00 EDT

  GSK Consumer Healthcare is voluntarily recalling five lots (listed below) of Benefiber Healthy Shape Prebiotic Fiber Supplement powder and Benefiber Prebiotic Fiber Supplement powder due to the potential for green plastic pieces or shavings from bottle caps to be present in the product. There is a p

CME America Provides Update on Two Previously Announced Voluntary Recalls Related to Ambulatory Infusion Pumps and Sets
Mon, 27 Apr 2020 00:00:00 EDT

  CME America, a wholly owned subsidiary of BD (Becton, Dickinson and Company), a leading global medical technology company, today issued the following update regarding two previously announced voluntary recalls, one related to all models of CMEAmerica BodyGuard® infusion pumps (FDA Recall Number: Z-1

What's New: Drugs RSS Feed

Drugs
Fri, 29 May 2020 16:56:33 EDT

  Consumer articles about over-the-counter and prescription drugs.

Consumer Updates
Fri, 29 May 2020 16:53:02 EDT

  Get timely, reliable, health and safety information about food, drugs, medical devices, vaccines, pet food, pet medicine and more.

FDA Voices on Policy
Fri, 29 May 2020 16:14:00 EDT

  FDA Voices on Policy

FDA Voices
Fri, 29 May 2020 16:08:53 EDT

  Insights into the agency's work in the areas of medical products, food, tobacco, policy, consumer safety and enforcement.

Understanding the Regulatory Terminology of Potential Preventions and Treatments for COVID-19
Fri, 29 May 2020 15:58:13 EDT

  There are no FDA-approved coronavirus preventions or treatments. Researchers are studying new drugs, and drugs approved for other conditions, as possible preventions or treatments for COVID-19. The language describing possible preventions or treatments can be confusing. Here’s what those terms mean.

Search List of Extended Use Dates to Assist with Drug Shortages
Fri, 29 May 2020 15:19:51 EDT

  This is to update and consolidate the extended use date information posted previously to assist with drug shortage (6/15/17 to present).

Over-The-Counter Monograph User Fee Program (OMUFA)
Fri, 29 May 2020 15:09:33 EDT

  A user fee program for nonprescription (over-the-counter or OTC) monograph drugs would be a potential funding mechanism to supplement congressional non user-fee appropriations.

Bringing a Cancer Doctor’s Perspective to FDA’s Response to the COVID-19 Pandemic
Fri, 29 May 2020 14:44:25 EDT

  During the unprecedented COVID-19 pandemic, the FDA recognizes that there has been public interest around expediting the development and availability of a number of potential treatment options.

What's New Related to Drugs
Fri, 29 May 2020 14:05:35 EDT

  Want to know what's new on drugs from FDA? This page provides quick links to the latest on a variety of topics including: drug approvals, safety warnings, drug shortages, etc.

Warning Letters 2020
Fri, 29 May 2020 12:40:52 EDT

  Matters described in FDA warning letters may have been subject to subsequent interaction between FDA and the recipient of the letter that may have changed the regulatory status of the issues discussed in the letter.

COVID MyStudies Application (App)
Fri, 29 May 2020 12:37:54 EDT

  FDA is making its MyStudies app available to investigators as a free platform to obtain informed consent securely from patients for eligible clinical trials when face-to-face contact is not possible or practical due to COVID-19 control measures.

FDA’s MyStudies Application (App) Technical Background
Fri, 29 May 2020 12:28:27 EDT

  FDA is making its MyStudies app available to investigators as a free platform to obtain informed consent securely and remotely.

Pescatlantic Group, LLC - 496990 - 05/26/2020
Fri, 29 May 2020 11:29:13 EDT

  Seafood HACCP/CGMP for Foods/Adulterated/Insanitary Conditions

Development Considerations of Antifungal Drugs to Address Unmet Medical Need - 08/04/2020 - 08/04/2020
Fri, 29 May 2020 11:07:05 EDT

  Clinical Trial Design Considerations for the Development of Antifungal Drugs

Shoreside Enterprises Inc. - 422722 - 05/26/2020
Fri, 29 May 2020 11:06:16 EDT

  Unapproved New Drugs/Misbranded

FDA In Brief: FDA Takes Actions to Enhance Utility of the Orange Book
Fri, 29 May 2020 10:06:29 EDT

  Today, the FDA published the draft guidance “Orange Book: Questions and Answers” to help stakeholders and the public effectively use the Orange Book, as well as two Federal Register notices to solicit comments on Orange Book enhancements and patent listings.

Anesthetic and Analgesic Drug Products Advisory Committee Charter
Fri, 29 May 2020 10:02:01 EDT

  This is the Charter for the Anesthetic and Analgesic Drug Products Advisory Committee.

Quadrant Sales & Marketing, Inc. - 607625 - 05/28/2020
Fri, 29 May 2020 10:00:04 EDT

  Unapproved New Drug Products Related to Coronavirus Disease 2019 (COVID-19)

StayWell Copper Products - 607773 - 05/28/2020
Fri, 29 May 2020 10:00:04 EDT

  Unapproved and Misbranded Products Related to Coronavirus Disease 2019 (COVID-19)

Drug Trials Snapshots
Fri, 29 May 2020 09:44:59 EDT

  Drug Trials Snapshots: breaking down the what, how and why. Drug Trials Snapshots is part of an overall FDA effort to make demographic data more available and transparent. Drug Trials Snapshots provide consumers with information about who participated in clinical trials that supported the FDA approval of new drugs. The information provided in these Snapshots also highlights whether there were any differences in the benefits and side effects among sex, race and age groups.

Whats New Vaccines Blood Biologics RSS Feed

Studies on the Safety and Efficacy of Plasma-derived Products and Their Recombinant Analogs
Fri, 29 May 2020 17:18:34 EDT

  A description of Basil Golding's research program and related publications.

Consumer Updates
Fri, 29 May 2020 16:53:02 EDT

  Get timely, reliable, health and safety information about food, drugs, medical devices, vaccines, pet food, pet medicine and more.

FDA Voices on Policy
Fri, 29 May 2020 16:14:00 EDT

  FDA Voices on Policy

Improving Safety and Potency Testing of Allergen Extracts
Fri, 29 May 2020 16:13:10 EDT

  A description of Jay Slater's research program and related publications.

FDA Voices
Fri, 29 May 2020 16:08:53 EDT

  Insights into the agency's work in the areas of medical products, food, tobacco, policy, consumer safety and enforcement.

Understanding the Regulatory Terminology of Potential Preventions and Treatments for COVID-19
Fri, 29 May 2020 15:58:13 EDT

  There are no FDA-approved coronavirus preventions or treatments. Researchers are studying new drugs, and drugs approved for other conditions, as possible preventions or treatments for COVID-19. The language describing possible preventions or treatments can be confusing. Here’s what those terms mean.

Cellular, Tissue and Gene Therapies Advisory Committee May 8, 2020 Meeting Announcement - 05/08/2020 - 05/08/2020
Fri, 29 May 2020 10:24:33 EDT

  This is the main page for the CBER Cellular, Tissue and Gene Therapies Advisory Committee May 8, 2020 Meeting Announcement.

Patient Listening Sessions
Thu, 28 May 2020 17:18:22 EDT

  Patient Listening Sessions led by FDA’s Patient Affairs Staff provide an opportunity for medical product Centers to engage with patients, caregivers, and their advocates about their experience with a disease or condition.

Exceptions and Alternative Procedures Approved Under 21 CFR 640.120
Thu, 28 May 2020 13:46:39 EDT

  Title 21 Code of Federal Regulations 640.120(a) - The Director, Center for Biologics Evaluation and Research, may approve an exception or alternative procedures to any requirement in subchapter F (Biologics) of Chapter I (Parts 600 - 680) of title 21 of the Code of Federal Regulations regarding bloo

What’s New for Biologics
Thu, 28 May 2020 12:51:59 EDT

  Latest news from the Center for Biologics Evaluation and Research

YESCARTA (axicabtagene ciloleucel)
Thu, 28 May 2020 08:51:15 EDT

  YESCARTA is a CD19-directed genetically modified autologous T cell immunotherapy indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy, including diffuse large B-cell lymphoma (DLBCL) not otherwise specified, primary mediastinal large B-cell lymphoma, high grade B-cell lymphoma, and DLBCL arising from follicular lymphoma.

Coronavirus (COVID-19) Update: FDA Provides New Tool to Aid Development and Evaluation of Diagnostic Tests That Detect SARS-CoV-2 Infection
Wed, 27 May 2020 21:41:18 EDT

  FDA new step to support the evaluation of diagnostic tests for COVID-19, by providing a SARS-CoV-2 reference panel. Reference panels are needed to ensure the quality of the tests, validation of new assays, test calibration, and monitoring of assay performance.

Coronavirus (COVID-19) Update: Daily Roundup May 27, 2020
Wed, 27 May 2020 20:45:50 EDT

  Coronavirus (COVID-19) Update: Daily Roundup

DG Gel 8 ABO/Rh (2D)
Wed, 27 May 2020 15:27:01 EDT

  The DG Gel 8 ABO/Rh (2D) card is for the determination of ABO forward and reverse group, and RhD antigen on the surface of red blood cells of human blood samples. For use with the DG Gel System. For in vitro diagnostic use.

Blood Safety: Developing Methods to Reduce Infectious Agents in Blood and Related Products and Identifying Biomarkers of Stored Blood Cells
Wed, 27 May 2020 12:55:15 EDT

  A description of C. D. Atreya's research program and related publications.

Evaluation of Safety and Potency of Viral Vaccines Based on Analysis of Molecular Consistency
Wed, 27 May 2020 12:40:33 EDT

  A description of Konstantin Chumakov's research program and related publications.

Impact of Immunity Induced by Viral and DNA Products
Wed, 27 May 2020 12:30:30 EDT

  A description of Suzanne Epstein's research program and related publications.

Standards for the Prompt Review of Efficacy Supplements, Including Priority Efficacy Supplements
Wed, 27 May 2020 08:35:00 EDT

  Standards for the Prompt Review of Efficacy Supplements, Including Priority Efficacy Supplements Guidance for Industry
Posted May 1998


Plasma Derived from Therapeutic Plasma Exchange
Tue, 26 May 2020 09:54:23 EDT

  In response to the large public interest generated by several publications which suggested that the antiglobulin crossmatch was unnecessary in many situations, the FDA sponsored a workshop in December 1981 on "The Role of Compatibility Tests."

Recommendations for the Management of Donor and Units that are Initially Reactive for Hepatitis B Surface Antigen (HBsAg)
Tue, 26 May 2020 09:52:42 EDT

  These recommendations set forth a series of procedures by which an initially HBsAg reactive donor may be reevaluated by a blood establishment, providing that all other donor suitability requirements are met.







 
 

Contact Us


Corporate Headquarters


Practical Compliance Solutions
One Orient Way - Suite F156
Rutherford, NJ 07070
Phone: 201-728-8809


40.827731 N 74.101029 W

Connect With Us

   
 
 
© 2002 - 2020 - Copyright Practical Compliance Solutions - All rights reserved